{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:54:09Z","timestamp":1772794449306,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00387","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:58:46Z","timestamp":1569891526000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Drug-Related Receptors in Children With Dilated Cardiomyopathy"],"prefix":"10.3389","volume":"7","author":[{"given":"Qing","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.hfc.2010.05.002","article-title":"The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years","volume":"6","author":"Wilkinson","year":"2010","journal-title":"Heart Fail Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE study research group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cardfail.2005.11.001","article-title":"Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure","volume":"12","author":"Price","year":"2006","journal-title":"J Card Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"H818","DOI":"10.1152\/ajpheart.00673.2016","article-title":"Exosomes from pediatric dilated cardiomyopathy patients modulate a pathological response in cardiomyocytes","volume":"312","author":"Jiang","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejphar.2009.08.039","article-title":"Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1","volume":"622","author":"Hauck","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S370","DOI":"10.1054\/jcaf.2002.129267","article-title":"Adrenergic pathways and left ventricular remodeling","volume":"8","author":"Dorn","year":"2002","journal-title":"J Card Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"39168","DOI":"10.1074\/jbc.M506760200","article-title":"Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium","volume":"280","author":"Hambleton","year":"2005","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1253\/circj.CJ-12-0666","article-title":"Left ventricular noncompaction: a diagnostically challenging cardiomyopathy","volume":"76","author":"Paterick","year":"2012","journal-title":"Circ J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.108.815712","article-title":"Waiting list mortality among children listed for heart transplantation in the United States","volume":"119","author":"Almond","year":"2009","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2009.11.059","article-title":"The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy","volume":"55","author":"Kantor","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJM198006193022501","article-title":"Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure","volume":"302","author":"Dzau","year":"1980","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/00005344-198309000-00014","article-title":"Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals","volume":"5","author":"Alousi","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10741-011-9262-2","article-title":"New roles for renin and prorenin in heart failure and cardiorenal crosstalk","volume":"17","author":"Schroten","year":"2012","journal-title":"Heart Fail Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00424-017-2005-z","article-title":"The (pro)renin receptor and its interaction partners","volume":"469","author":"Peters","year":"2017","journal-title":"Pflugers Arch"},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/eurheartj\/ehs229","article-title":"Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy","volume":"35","author":"Miyamoto","year":"2014","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/CIRCHEARTFAILURE.114.001218","article-title":"Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy","volume":"8","author":"Nakano","year":"2015","journal-title":"Circ Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","first-page":"83323","DOI":"10.18632\/oncotarget.18312","article-title":"Safety of the neprilysin\/renin-angiotensin system inhibitor LCZ696","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jacc.2016.04.047","article-title":"Influence of sacubitril\/valsartan (LCZ696) on 30-day readmission after heart failure hospitalization","volume":"68","author":"Desai","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00387\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:58:47Z","timestamp":1569891527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00387\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":25,"alternative-id":["10.3389\/fped.2019.00387"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00387","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"article-number":"387"}}